Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

Breast-conserving therapy yields better 10-year outcomes than mastectomy for...

Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht...

Breast-conserving therapy yields better 10-year outcomes than mastectomy for early-stage patients ( Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands )

Analysis of blood samples finds ESR1 gene mutations are prevalent and...

Dr Sarat Chanderlapaty - Memorial Sloan Kettering Cancer Center, New York, USA

Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall survival ( Dr Sarat Chanderlapaty - Memorial Sloan Kettering Cancer Center, New York, USA )

Breast-conserving therapy yielded better outcomes than mastectomy for early...

Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht...

Breast-conserving therapy yielded better outcomes than mastectomy for early-stage patients ( Dr Sabine Siesling - Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands )

Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by...

Dr Reuben Harris - Howard Hughes Medical Institute, Minneapolis, USA

Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B ( Dr Reuben Harris - Howard Hughes Medical Institute, Minneapolis, USA )

Denosumab improves disease-free survival for postmenopausal patients with HR...

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )

Test to identity which breast cancer patients will respond to platinum-based...

Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake...

Test to identity which breast cancer patients will respond to platinum-based chemotherapy ( Dr Johnathan Lancaster - Chief Medical Officer of Myriad Genetics, Salt Lake City, USA )

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant...

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )

Denosumab improves disease-free survival for postmenopausal HR-positive breast...

Prof Michael Gnant - Medical University of Vienna, Vienna, Austria

Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )

Women with luminal A subtype of breast cancer did not benefit from adjuvant...

Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada

Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )

Pathologic complete response to presurgery chemo improves survival for triple...

Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )

Telepathology in Tanzania

Dr Matteo Botteghi - Associazione Vittorio Tison Onlus, Italy

Telepathology in Tanzania ( Dr Matteo Botteghi - Associazione Vittorio Tison Onlus, Italy )

PCA3 test for prostate cancer in Africa

Dr Imane Abdellaoui Maane - Moroccan Foundation for Advanced Science...

PCA3 test for prostate cancer in Africa ( Dr Imane Abdellaoui Maane - Moroccan Foundation for Advanced Science, Innovation and Research )

More from ecancer